Challenges/barriers for moving forward Ernesto Jaramillo WHO/Stop TB Department Palliative Care and M/XDR-TB 18-19 November, 2010 Geneve, Switzerland.

Slides:

Advertisements

Similar presentations

Antiretroviral Therapy Standard Core Indicators. Emergency Plan for AIDS Relief 2 million people reached with ART 7 million new infects prevented 10 million.

Advertisements

Stop TB Strategy Planning Frameworks Mukund Uplekar TB Strategy, Operations and Health Systems, Stop TB Department, WHO.

The Role of Palliative Care in HIV/AIDS Management in Botswana

February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.

Improving diagnosis TB laboratory strengthening.

Renewing Health Canada’s strategy against TB for First Nations on-reserve Provincial Primary Care Tuberculosis Education Day October 28, 2011 Presented.

Quality of Life: 101.

State Health Departments: Focused on the Next Level Ann Robbins Texas Department of State Health Services National Alliance of State and Territorial AIDS.

The role of specialist palliative care: establishing what needs for happen to ensure that people die well in Ireland. Dr Karen Ryan, Consultant in Palliative.

Scaling up Prevention of Mother to Child Transmission of HIV (PMTCT): What Will it Take to Eliminate MTCT? Jessica Rodrigues Presentation for UNICEF Written.

Engaging workplaces in TB care and control Evidence base and guidance framework Hannah Monica Yesudian Dias Stop TB Department World Health Organization.

 National Hospice & Palliative Organization, 2008 SEC. § : QUALITY ASSESSMENT AND PERFORMANCE IMPROVEMENT SUBPART C: PATIENT CARE.

Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.

COMMUNITY SYSTEMS STRENGTHENING Keynote address by PROF MIRIAM K. WERE ON THE OCCASION OF THE AMREF HEALTH AFRICA INTERNATIONAL CONFERENCE, 2014 NAIROBI,

COUNTRY XEPERIENCE AND RESPONSE TO MDR AND XDR TUBERCULOSIS PRESENTED AT THE WHO TB/HIV PLANNING MEETING, ADDIS ABBABA, 11-12, NOVEMBER 2008 BY MS GUGU.

Concept Note on HIV Mongolia Process and key components of Funding Request to Global Fund.

Module 3. Session 2 Introduction to quality in health care.

African Business Leaders on Health GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 2010 Technical Assistance.

Unit 9. Human resource development for TB infection control TB Infection Control Training for Managers at National and Subnational Level.

DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.

“Managing Regionalism for Health” RMI Kumiti Presentation 52 nd Meeting of the Pacific Islands Health Officers Association June 11-15, 2012 Guam.

Multi-drug resistant tuberculosis: Progress and challenges in South Africa Dr S. Moyo HIV/AIDS, Sexually Transmitted Infections and TB research (HAST)Programme.

A decentralized model of care for drug-resistant tuberculosis in a high HIV prevalence setting Cheryl McDermid, Helen Cox, Simiso Sokhela, Gilles van Cutsem,

Health Planning and Implementation in post-conflict Afghanistan by Laurence Laumonier-Ickx, MD November 8, 2006.

Overcoming the HIV/AIDS Epidemic in Ukraine Key issues for the Consolidation Group A National programme supported by the Global Fund.

Health Data Workgroup September 28,  Response to State Health Plan ◦ Develop a roadmap for continuing to build Maine’s health data, analysis and.

Availability Accessibility Acceptability Quality Satisfaction Continuity of care Impacts Reach and outcomes Health Sector Non-Health Sector Outputs Education.

Session 11: MDR & XDR-TB: How Can Business Help Stem the Tide?

Community and health facility budget advocacy issues around HIV/AIDS and TB service delivery at district level 5 th SA AIDS Conference 8 May 2011.

6 th Biannual Joint HIV Sector Review Meeting Nov 11-13,2014 Ministry of Health and Social Welfare Mwanaisha Nyamkara, NTLP Werner Maokola, NACP Nov 11,

Resource Needs Model Rachel Sanders October 28 th, 2010.

Sources of Limited Access to Treatment High Cost of Treatment Lack of Pilot Projects Lack of Evidence Lack of Policy Lack of Demand.

Paula Munderi Department of Essential Drugs and Medicines Policy World Health Organization Access to essential medicines for HIV/AIDS - update on WHO activities.

1 Oct 2005 WHO/STB/THD World Health Organization 4 th Meeting of Subgroup on laboratory capacity strengthening Paris, France, October Ernesto Jaramillo.

Swiss Re – Pandemic Risk Talk Ethical issues in palliative care for patients with M/XDR-TB Geneva, 19 November 2010 Palliative Care and M/XDR-TB meeting.

Tanzanian German Programme to Support Health The Health Financing Component Supporting Social Health Protection and Health Financial Management in Tanzania.

1 DEWG meeting October 2009 Human Resource Development for TB Control (HRD-TB) Sub Group within the DEWG of the Stop TB Partnership. Wanda Walton.

TBS 2008-H. Tata & M. Babaley Mapping and In-depth Assessment of Medicines Procurement and Supply Systems WHO Technical Briefing Seminar 17 th -21 st November.

Mobile content for frontline health workers mHealth Workshop October 15 th 2013.

Interactions between health systems and Global Health Initiatives – what we learnt to inform research methodology Joseph Perriëns on behalf of Badara Samb.

Exploring financing options NATIONAL TB CONTROL OF VIETNAM.

TB infection control and prevention of XDR Group II.

HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.

Intensified TB case finding and infection control in Tanzania – opportunities and challenges Denis Tindyebwa Technical Director EGPAF Tanzania.

Adult Immunization: Goals, Challenges, and a role for the National Vaccine Advisory Committee October 22, 2007 Raymond A. Strikas, MD National Vaccine.

The Gambia Roadmap to Achieve RBM Targets September 2009 – December 2010.

Global Fund: Contributions to the Global Health Workforce 2 – 3 February 2012 Irish Forum for Global Health Conference.

NFM: Modular Template Measurement Framework: Modules, Interventions and Indicators LFA M&E Training February

Supporting measurement & improvement of primary health care (PHC) at the facility and community levels Dr. Jennifer Adams, Deputy Assistant Administrator,

11 Laboratory Quality Improvement for clinical HIV/AIDS Services in the Uniformed Forces Mwaibako, J, Shija, L; Haverkamp, G; van den Hombergh; Katebalila,

Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.

Stop TB in China Challenges, Constraints & Actions Dr Wang Longde Vice Minister of Health China 24 March 2004.

Overview and breakdown of the KPI results

Palliative Care and M/XDR-TB Global burden of M/XDR-TB

Current harm reduction program at outreach

Increased access to quality TB drugs

Find and Treat All Missing Persons with TB

Effective Quality Assurance in Healthcare, Kyrgyzstan

Stop TB Partnership Secretariat (TBP) M. Espinal, Executive Secretary

Key issues in DOTS implementation

China 2010 UNGASS Country Progress Report

Conclusions and recommendations – first draft

When Is Intrathecal Drug Delivery Appropriate?

XDR/MDR-TB Response Sub Group on Advocacy and Resource Mobilization

5th DEWG meeting Conclusions

When Is Intrathecal Drug Delivery Appropriate?

South Africa: From ProTest to Nationwide Implementation

The STOP TB Strategy – 2009 VISION: A TB-free world

Dr Ruitai Shao Programme Management Adviser

Pharmacy Sector SECTOR COMMITMENT TO END TB

Presentation transcript:

Challenges/barriers for moving forward Ernesto Jaramillo WHO/Stop TB Department Palliative Care and M/XDR-TB November, 2010 Geneve, Switzerland

Non-exhaustive list of challenges Awareness Advocacy Assessment of need Policy-guidelines Financing Human resources Models for palliative care in M/XDR-TB Needs for technical assistance Monitoring and evaluation (indicators, targets, goals) Drug management in palliative care for TB

AWARENESS What else apart from anti-TB drugs are patients in need of?

ADVOCACY Health care workers and health care systems not only have the ethical duty but CAN deliver effective palliative care

Universal access to palliative care must match universal access to diagnosis and treatment of M/XDR-TB

Policy-guidelines …in need of updating

Financing What and hw to budget and fund palliative care in M/XDR-TB?

Models for palliative care in M/XDR-TB

Human resources

Needs of technical assistance

Monitoring and evaluation (indicators, targets, goals) How to measure coverage, quality, and impact of palliative care in the response to M/XDR-TB?

Drug management in palliative care for TB

Which are the challenges in the health systems for scaling up palliative care? Health System Building Blocks Bottlenecks Service delivery Health workforceInformation Medical products and technologies Health financing Leadership and governance Still major gaps in TB control Extremely weak M/XDR- TB management and care Health workforce crisis Inadequate laboratories Quality of anti-TB drugs not assured Limited access to drugs for pain relief Absent infection control Insufficient body of evidence on PC in TB Major financial gaps

What means a patient-centred approach in TB care and control without palliative care?